Hemopoietic growth factors have the ability to promote and proliferation and differentiation of hematopoietic progenitors into mature blood cells.
County stimulating factors are made up of a growth factors regulating the growth and differentiation of cells toward the myeloid and erythroid lineages.
Myeloid growth factors such as granulocyte CSFs are primarily used to reduce the incidence of febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive chemotherapy, to enable safe delivery of chemotherapy on schedule.
Erythropoiesis stimulating agents include epoetin alpha and darboetin alpha are primarily used to manage cancer induced anemia and chemotherapy induced anemia.
Thrombopoietin receptor agonists including romiplostim are platelet growth factors used to manage chemotherapy induced thrombocytopenia.